Skip to main content
. 2021 Dec 17;13(24):6354. doi: 10.3390/cancers13246354

Table 1.

PI3K/AKT differentially expressed genes in pancreatic cancer according to the PED database. Fold-change for each probe is based on the comparison between tumour (n = 96) and normal tissue samples (n = 57) (unpaired t-test).

Pathway Gene Pathway Activator (↑) or Repressor (↓) Probe Fold-Change p-Value Expression Higher
PI3K/AKT ITGA4 205884_at 2.26 <0.0001 Tumour
205885_s_at 2.21 <0.0001
SFN 209260_at 2.64 0.000154 Tumour
33322_i_at 5.65 <0.0001
33323_r_at 5.47 <0.0001
PPP2R5C 1557718_at 2.47 <0.05 Tumour
PIK3CD 203879_at 2.08 <0.001 Tumour
ITGA2 205032_at 3.07 <0.0001 Tumour
227314_at 4.77 <0.0001
PIK3R1 212239_at 1.92 <0.05 Tumour
AKT3 212609_s_at 1.9 <0.0001 Tumour
222880_at 1.58 <0.0001
EIF4EBP1 221539_at −2.46 <0.0001 Normal Tissue
INPP5D 203332_s_at 2.11 <0.001 Tumour
JAK2 205842_s_at 2.05 <0.0001 Tumour
MRAS 225185_at 1.84 <0.0001 Tumour
MAP2K2 213490_s_at −2.03 <0.0001 Normal Tissue
MAP3K8 205027_s_at 3.48 <0.0001 Tumour
RAC2 213603_s_at 3.51 <0.0001 Tumour
PTEN 1556006_s_at 3.88 <0.05 Tumour